Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 29;15(1):e34344.
doi: 10.7759/cureus.34344. eCollection 2023 Jan.

Lysozyme-Induced Nephropathy: A Diagnosis Not to Forget

Affiliations
Case Reports

Lysozyme-Induced Nephropathy: A Diagnosis Not to Forget

Núria Paulo et al. Cureus. .

Abstract

Kidney injury in hematologic malignancies can manifest in many ways. We present a case report of a 44-year-old female with de novo acute myeloid leukemia (AML) and acute kidney injury. Following the etiological investigation, lysozyme-induced nephropathy was believed to be the most probable cause of renal injury. Intensive cytoreduction and chemotherapy were started and the patient's cytopenias and kidney injury have improved. This case highlights the importance of recognizing lysozyme-induced nephropathy as a form of kidney injury in AML. Despite being frequently underrecognized, a precocious diagnosis may impact the patient's prognosis.

Keywords: acute kidney injury; case report; hematologic malignancies; lysozyme; lysozyme-induced nephropathy.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Evolution of serum creatinine and electrolytes during inpatient stay in relation to treatment.

References

    1. Kidney involvement in leukemia and lymphoma. Luciano RL, Brewster UC. Adv Chronic Kidney Dis. 2014;21:27–35. - PubMed
    1. Progressive kidney failure in chronic myelomonocytic leukaemia: don't forget lysozyme damage. Hillen JM, Raemaekers JM, Steenbergen EJ, Wetzels JF, Verhave JC. https://pubmed.ncbi.nlm.nih.gov/30465656/ Neth J Med. 2018;76:407–410. - PubMed
    1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Döhner H, Estey E, Grimwade D, et al. Blood. 2017;129:424–447. - PMC - PubMed
    1. Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy. Ballo O, Eladly F, Büttner S, et al. Ann Hematol. 2021;100:1159–1167. - PMC - PubMed
    1. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Lahoti A, Kantarjian H, Salahudeen AK, et al. Cancer. 2010;116:4063–4068. - PMC - PubMed

Publication types

LinkOut - more resources